ReviewJournal of clinical medicine2021

Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Anne Dyhl-Polk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.